<?xml version="1.0" encoding="UTF-8"?>
<ref id="B11">
 <label>11.</label>
 <mixed-citation publication-type="webpage">
  <person-group person-group-type="author">
   <collab>European Medicines Agency (EMA)</collab>
  </person-group>
  <article-title>Pegylated Liposomal Doxorubicin Hydrochloride Concentrate for Solution 2 mg/ml Product-Specific Bioequivalence Guidance</article-title>. (
  <year>2018</year>). Available online at: 
  <ext-link ext-link-type="uri" xlink:href="https://www.ema.europa.eu/en/documents/scientific-guideline/pegylated-liposomal-doxorubicin-hydrochloride-concentrate-solution-2-mg/ml-product-specific-bioequivalence-guidance_en.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.ema.europa.eu/en/documents/scientific-guideline/pegylated-liposomal-doxorubicin-hydrochloride-concentrate-solution-2-mg/ml-product-specific-bioequivalence-guidance_en.pdf</ext-link>.
 </mixed-citation>
</ref>
